Janux Therapeutics, Inc.
JANX
11 insider filings · Latest: Jul 8, 2026
Common Stock Transactions
| Txn Date | Accepted | Insider | Type | Shares | Avg Price | Value | Shares Owned | Filing |
|---|---|---|---|---|---|---|---|---|
| Nov 1, 2024 | Nov 1 9:05 PM | Reardon Tighe | Proposed Sale | 5,202 | $53.44 | $278.0K | — | View → |
| Nov 1, 2024 | Nov 1 9:02 PM | Lichter Jay | Proposed Sale | 1,139 | $53.31 | $60.7K | — | View → |
| Nov 1, 2024 | Nov 1 8:30 PM | Avalon Ventures XI, L.P. | Proposed Sale | 56,440 | $53.66 | $3.0M | — | View → |
| Nov 1, 2024 | Nov 1 8:24 PM | Avalon BioVentures SPV I, L.P. | Proposed Sale | 57,627 | $53.66 | $3.1M | — | View → |
| Nov 1, 2024 | Nov 1 8:17 PM | Avalon BioVentures I, LP | Proposed Sale | 10,934 | $53.66 | $586.7K | — | View → |
| Nov 1, 2024 | Nov 1 8:07 PM | Reardon Tighe | Proposed Sale | 2,999 | $52.99 | $158.9K | — | View → |
| Oct 28, 2024 | Oct 28 9:07 PM | Reardon Tighe | Proposed Sale | 15,122 | $53.41 | $807.7K | — | View → |
| Oct 28, 2024 | Oct 28 9:01 PM | Lichter Jay | Proposed Sale | 3,419 | $53.51 | $183.0K | — | View → |
| Oct 28, 2024 | Oct 28 8:46 PM | Reardon Tighe | Proposed Sale | 9,061 | $53.36 | $483.5K | — | View → |
| Oct 25, 2024 | Oct 25 8:57 PM | Avalon Ventures XI, L.P. | Proposed Sale | 169,320 | $53.33 | $9.0M | — | View → |
| Oct 25, 2024 | Oct 25 8:51 PM | Avalon BioVentures I, LP | Proposed Sale | 32,800 | $53.33 | $1.7M | — | View → |
| Oct 25, 2024 | Oct 25 8:44 PM | Avalon BioVentures SPV I, L.P. | Proposed Sale | 172,880 | $53.33 | $9.2M | — | View → |
| Oct 24, 2024 | Oct 25 4:37 PM | Reardon Tighe | Proposed Sale | 21,760 | $52.80 | $1.1M | — | View → |
| Oct 24, 2024 | Oct 24 9:53 PM | Lichter Jay | Proposed Sale | 4,921 | $53.37 | $262.7K | — | View → |
| Oct 24, 2024 | Oct 24 9:04 PM | Reardon Tighe | Proposed Sale | 217,690 | $5.28 | $1.1M | — | View → |
| Oct 23, 2024 | Oct 23 9:59 PM | Avalon BioVentures SPV I, L.P. | Proposed Sale | 248,797 | $51.23 | $12.7M | — | View → |
| Oct 23, 2024 | Oct 23 9:38 PM | Avalon BioVentures I, LP | Proposed Sale | 47,203 | $51.23 | $2.4M | — | View → |
| Oct 23, 2024 | Oct 23 9:07 PM | Avalon Ventures XI, L.P. | Proposed Sale | 243,672 | $51.23 | $12.5M | — | View → |
| Oct 23, 2024 | Oct 23 8:36 PM | Reardon Tighe | Proposed Sale | 13,039 | $51.01 | $665.1K | — | View → |
| Oct 21, 2024 | Oct 21 8:43 PM | Reardon Tighe | Proposed Sale | 10,769 | $49.43 | $532.3K | — | View → |
Stock Options & Derivatives
| Txn Date | Accepted | Insider | Type | Shares | Exercise Price | Shares Owned | Filing |
|---|---|---|---|---|---|---|---|
| Jul 8, 2026 | Jul 11 12:00 AM | Campbell David AlanDirector, President and CEO | Option Exercise | 7,000 | $4.21 | 697,550(D) | View → |
| Jun 11, 2026 | Jun 13 12:30 AM | RA CAPITAL MANAGEMENT, L.P.Director, 10% Owner | Grant/Award | 15,500 | $13.66 | 15,500(I) | View → |
| Jun 11, 2026 | Jun 13 12:00 AM | Jake SimsonDirector | Grant/Award | 15,500 | $13.66 | 15,500(D) | View → |
| Jun 11, 2026 | Jun 13 12:00 AM | Winston KungDirector | Grant/Award | 15,500 | $13.66 | 15,500(D) | View → |
| Jun 11, 2026 | Jun 13 12:00 AM | Natasha HerndayDirector | Grant/Award | 15,500 | $13.66 | 15,500(D) | View → |
| Jun 11, 2026 | Jun 13 12:00 AM | Eric DobmeierDirector | Grant/Award | 15,500 | $13.66 | 15,500(D) | View → |
| Jun 11, 2026 | Jun 13 12:00 AM | Vickie L CappsDirector | Grant/Award | 15,500 | $13.66 | 15,500(D) | View → |
| Jun 11, 2026 | Jun 13 12:00 AM | Ronald W BarrettDirector | Grant/Award | 15,500 | $13.66 | 15,500(D) | View → |
| Feb 2, 2026 | Feb 5 1:01 AM | William GoChief Medical Officer | Grant/Award | 154,000 | $13.99 | 154,000(D) | View → |